| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 4.68824 | 33 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 4.63598 | 32 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 4.67015 | 33 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 4.62749 | 31 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 4.82084 | 36 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 4.8068 | 37 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 6.93352 | 70 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 4.6815 | 33 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 4.7597 | 35 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 4.74643 | 35 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 4.53486 | 31 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 4.62514 | 32 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 4.49135 | 29 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.85741 | 38 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 4.33088 | 26 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 5.01329 | 41 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 4.75528 | 36 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 4.7279 | 35 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.3255 | 25 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 5.13481 | 40 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 4.71871 | 34 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 4.74445 | 35 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.71545 | 35 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 4.98091 | 40 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 4.87735 | 38 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 5.22323 | 46 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 4.71248 | 34 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.75693 | 35 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.56989 | 31 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 4.82551 | 36 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.50018 | 29 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 4.89214 | 38 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 4.76088 | 34 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 4.80488 | 37 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.62221 | 32 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 6.15476 | 60 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 4.60525 | 31 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 4.68762 | 33 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 4.66018 | 32 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 4.90711 | 39 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 4.78996 | 36 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 5.45846 | 49 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 4.81873 | 36 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.46026 | 29 |